Catawba River Capital REGN Holdings History
Catawba River Capital's Regeneron Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Catawba River Capital held 9,670.00 shares of Regeneron Pharmaceuticals Inc(REGN), totaling $6.13 Mil. This investment constitutes 3.73% of their stock portfolio, and Catawba River Capital now holds 0.01% of the outstanding Regeneron Pharmaceuticals Inc(REGN) stock.
The initial trade took place in 2021Q3. And since then Catawba River Capital has made 11 purchases of REGN, at an average price of $690.77, for a total of 17,001.00 shares. In addition, there have been 4 sales at an average price of $968.72 for 7,331.00 shares. Based on historical transaction data and REGN's current price of $547.36, Catawba River Capital's estimated gain on his REGN holdings is $650,891.67, reflecting a 5.54% gain to date.
Catawba River Capital REGN ($547.36) Holding Chart
Catawba River Capital REGN ($547.36) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
